Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Age
10–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
The subjects must have received study medication in Study A1281196.
In the investigator's opinion, the subject must be likely to continue to benefit from antipsychotic therapy and must have been free from any clinically significant safety concerns during the preceding double blind study.
You may not be if
Subjects who require treatment with drugs that are known to consistently prolong the QT interval.
Subjects who are judged by the investigator as being at imminent risk of suicide.
